| Q43157715 | "Unintentional" acetaminophen overdose on the rise: who is responsible? Dr Robert J Fontana is interviewed by Paul C Adams |
| Q35755804 | 23.4% Saline Decreases Brain Tissue Volume in Severe Hepatic Encephalopathy as Assessed by a Quantitative CT Marker |
| Q38115850 | Acute fulminant hepatic failure, encephalopathy and early CT changes. |
| Q93192662 | Acute liver failure |
| Q39761330 | Acute liver failure and liver assist devices |
| Q34377780 | Acute liver failure and liver transplantation |
| Q24647134 | Acute liver failure including acetaminophen overdose |
| Q64895800 | Acute liver failure: Peritransplant management and outcomes. |
| Q36054934 | Acute liver failure: Summary of a workshop |
| Q34105625 | Acute liver failure: a management challenge for the practicing gastroenterologist |
| Q91911417 | Akutes Leberversagen |
| Q80764514 | Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure |
| Q42726017 | Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management |
| Q36742935 | Brain edema in acute liver failure: can it be prevented? Can it be treated? |
| Q37232734 | Clinical management of acute liver failure: Results of an international multi-center survey |
| Q41717177 | Complications of Acute Liver Failure |
| Q51101241 | Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver Failure. |
| Q37778159 | Critical care management of patients before liver transplantation |
| Q37867071 | Critical care of the end-stage liver disease patient awaiting liver transplantation. |
| Q37346009 | Current concepts in the evaluation of patients for liver transplantation |
| Q37238381 | Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management |
| Q31163349 | Evaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in-vivo proton MR spectroscopy |
| Q81122094 | Fulminant hepatic failure: when the hepatologist meets the neurointensivist |
| Q38476804 | Hot topics in liver intensive care |
| Q92309968 | How to manage: acute liver failure |
| Q41517861 | Hypercoagulability progresses to hypocoagulability during evolution of acetaminophen-induced acute liver injury in pigs. |
| Q26865028 | Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology |
| Q36895300 | Intracranial Pressure Monitoring Demonstrates that Cerebral Edema Is Not Correlated to Hyperammonemia in a Child with Ornithine Transcarbamylase Deficiency |
| Q39930059 | Intracranial Pressure Monitoring in Acute Liver Failure: Institutional Case Series. |
| Q80002047 | Intracranial pressure monitoring in acute liver failure. A procedure with clear indications |
| Q80002008 | Intracranial pressure monitoring in patients with acute liver failure: a questionable invasive surveillance |
| Q35024385 | Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure |
| Q48278313 | Is it worthwhile to use cerebral microdialysis in patients with acute liver failure? |
| Q49890846 | Live donor liver transplantation for acute liver failure: A single center experience. |
| Q46843890 | Liver transplantation for acute liver failure: trying to define when transplantation is futile |
| Q36313395 | Liver transplantation: Advances and perioperative care |
| Q52659545 | Living Donor Liver Transplantation in Acute Liver Failure Patients with Grade IV Encephalopathy: Is Deep Hepatic Coma Still an Absolute Contraindication? A Successful Single-Center Experience. |
| Q91912288 | Management of Acute Liver Failure: A Pediatric Perspective |
| Q37571437 | Management of acute liver failure |
| Q37049603 | Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventions. |
| Q47723625 | Meeting report of the 2014 joint international congress of the International Liver Transplantation Society, Liver Intensive Care Group of Europe, and European Liver and Intestinal Association |
| Q33808975 | Mild hypothermia does not affect liver regeneration after partial hepatectomy in mice |
| Q37093069 | Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. |
| Q37619292 | Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review |
| Q38479704 | Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports |
| Q90648687 | Neurological Monitoring in Acute Liver Failure |
| Q91940432 | Neurological Monitoring in Acute Liver Failure |
| Q91598131 | Neurological Recovery After Recovery From Acute Liver Failure: Is it Complete? |
| Q47562001 | Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy |
| Q36041222 | Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. |
| Q33926131 | Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study |
| Q59810252 | Perioperative monitoring of intracranial pressure using optic nerve sheath diameter in paediatric liver transplantation |
| Q96128735 | Perspective of placenta derived mesenchymal stem cells in acute liver failure |
| Q33405129 | Potential applications of thromboelastography in patients with acute and chronic liver disease |
| Q80114738 | Predicting prognosis in acute liver failure: Ammonia and the risk of cerebral edema |
| Q38059302 | Preterm delivery in a parturient candidate for emergency liver transplantation after hepatitis B virus infection related fulminant liver failure |
| Q33892643 | Protocol based invasive intracranial pressure monitoring in acute liver failure: feasibility, safety and impact on management |
| Q27028034 | Recent advances in management of acute liver failure |
| Q36551050 | Recent developments in acute liver failure |
| Q46910848 | Reuse of liver graft from a brain dead recipient |
| Q89535233 | Serum osmolality, cerebrospinal fluid specific gravity and overt hepatic encephalopathy severity in patients with liver failure |
| Q42908286 | Serum proinflammatory cytokines correlate with diffusion tensor imaging derived metrics and 1H-MR spectroscopy in patients with acute liver failure |
| Q40113551 | Small-for-Size Syndrome: Bridging the Gap Between Liver Transplantation and Graft Recovery |
| Q37610828 | State-of-the-art management and monitoring of brain edema and intracranial hypertension in fulminant hepatic failure. A proposed algorithm |
| Q35917306 | Structured approach to treat patients with acute liver failure: A hepatic emergency |
| Q80990662 | The coagulopathy of acute liver failure and implications for intracranial pressure monitoring |
| Q42248339 | The complications and the position of the Codman MicroSensor™ ICP device: an analysis of 549 patients and 650 Sensors |
| Q37128774 | Therapeutic hypothermia for acute liver failure: toward a randomized, controlled trial in patients with advanced hepatic encephalopathy. |
| Q48456325 | Transcranial doppler sonography is useful for the decision-making at the point of care in patients with acute hepatic failure: a single centre's experience |
| Q42907021 | Treatment of Brain Edema in Acute Liver Failure |
| Q41150898 | Two-stage liver transplantation in a surgically complicated liver failure patient after hepatic tumor resection -A case report-. |
| Q90648668 | UPDATE IN HEPATIC ENCEPHALOPATHY - PART II |
| Q87121874 | Ultrasonographic optic nerve sheath diameter is correlated with arterial carbon dioxide concentration during reperfusion in liver transplant recipients |
| Q91902142 | [Acute liver failure] |